Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › artesunate

artesunate

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of artesunate

4 trials tracked of artesunate: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 12 citations.

4Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 3 1 Phase 2 2
  1. Phase 4 Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical Cure Completed · 12 cited
  2. Phase 3 Chloroquine Alone or in Combination for Malaria in Children in Malawi Completed
  3. Phase 2 Safety and Efficacy Study of IV Artesunate to Treat Malaria Completed
  4. Phase 2 Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Evaluating Mefloquine Dosage Effects and Tolerability in Artesunate-Mefloquine Regimens for Malaria
Pediatrics Meta-analysis
Evaluating Mefloquine Dosage Effects and Tolerability in Artesunate-Mefloquine Regimens for Malaria Meta-analysis shows mefloquine dose impacts malaria recurrence in children
A meta-analysis of individual patient data reveals that while higher mefloquine doses reduce recrudescence, early vomiting remains a signifi…
A large study of over 6,000 patients reveals how specific doses of mefloquine can help prevent malaria from returning in young children.
Aug 25, 2026
Systematic review of artesunate for cytomegalovirus in immunocompromised patients
Infectious Disease Meta-analysis
Systematic review of artesunate for cytomegalovirus in immunocompromised patients A Malaria Drug Shows Promise Against a Common Virus
This systematic review synthesizes evidence from 46 studies regarding artesunate for cytomegalovirus in immunocompromised individuals. The a…
A well-known malaria drug called artesunate may offer a new weapon against a common virus that causes serious harm in people with weakened i…
Frontiers May 7, 2026